Luo Xiong-Fei, Zhang Zhi-Jun, Song Zi-Long, Wang Zhi-Ping, Yan Jia-Xuan, Liu Xiao-Fei, Peng Li-Zeng, Yang Cheng-Jie, Liu Ying-Qian
School of Pharmacy, Lanzhou University, Lanzhou, China.
Department of Urology, Institute of Urology, Gansu Nephro-Urological Clinical Center, Key Laboratory of Urological Diseases in Gansu Province, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
Nat Prod Res. 2024 Aug 18:1-10. doi: 10.1080/14786419.2024.2392739.
With the intention of advancing our research on diverse C-20 derivatives of camptothecin (CPT), CPT derivatives bearing sulphonamide and sulfonylurea chemical scaffolds and different substituent groups have been designed, synthesised and evaluated for cytotoxicity against four tumour cell lines, A-549 (lung carcinoma), KB (nasopharyngeal carcinoma), MDA-MB-231 (triple-negative breast cancer) and KBvin (an MDR KB subiline). As a result, all the synthesised compounds showed promising cytotoxic activity against the four cancer cell lines tested, and were more potent than irinotecan. Importantly, compounds , , and possessed better antiproliferative activity against all tested tumour cell lines with IC values of 0.0118 - 0.5478 μM, and resulted approximately to times more cytotoxic than topotecan against multidrug-resistant KBvin subline. Convincing evidences are achieved that incorporation of sulphonamide and sulfonylurea motifs into position-20 of camptothecin confers markedly enhanced cytotoxic activity against cancer cell lines.
为了推进我们对喜树碱(CPT)各种C-20衍生物的研究,设计、合成并评估了带有磺酰胺和磺酰脲化学支架以及不同取代基的CPT衍生物对四种肿瘤细胞系A-549(肺癌)、KB(鼻咽癌)、MDA-MB-231(三阴性乳腺癌)和KBvin(KB多药耐药亚系)的细胞毒性。结果,所有合成的化合物对所测试的四种癌细胞系均显示出有前景的细胞毒性活性,且比伊立替康更有效。重要的是,化合物 、 、 和 对所有测试的肿瘤细胞系具有更好的抗增殖活性,IC值为0.0118 - 0.5478 μM,并且对多药耐药的KBvin亚系的细胞毒性比拓扑替康高约 至 倍。有令人信服的证据表明,将磺酰胺和磺酰脲基序引入喜树碱的20位可显著增强对癌细胞系的细胞毒性活性。